摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-hydroxy-3-allyl-phenyl)-3-(2,4,5-trimethoxy-phenyl)-propenone | 649551-98-4

中文名称
——
中文别名
——
英文名称
1-(2-hydroxy-3-allyl-phenyl)-3-(2,4,5-trimethoxy-phenyl)-propenone
英文别名
(2E)-1-[2-Hydroxy-3-(prop-2-en-1-yl)phenyl]-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one;(E)-1-(2-hydroxy-3-prop-2-enylphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
1-(2-hydroxy-3-allyl-phenyl)-3-(2,4,5-trimethoxy-phenyl)-propenone化学式
CAS
649551-98-4
化学式
C21H22O5
mdl
——
分子量
354.403
InChiKey
HTCIJFRFZHYLPC-ZHACJKMWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    26
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-hydroxy-3-allyl-phenyl)-3-(2,4,5-trimethoxy-phenyl)-propenonesodium hydroxide双氧水 作用下, 以 甲醇 为溶剂, 反应 31.25h, 以42%的产率得到8-allyl-3-hydroxy-2-(2,4,5-trimethoxy-phenyl)-chromen-4-one
    参考文献:
    名称:
    [EN] FLAVONOID COMPOUNDS AS THERAPEUTIC ANTIOXIDANTS
    [FR] COMPOSES FLAVONOIDES EN TANT QU'ANTIOXYDANTS THERAPEUTIQUES
    摘要:
    描述了具有抗氧化活性的新型黄酮类化合物。公式(1)。已经证明这些化合物在生物系统中展现出抗氧化特性,其在防晒霜或护肤品中的用途,或用于治疗涉及氧化损伤的情况,特别是治疗或预防治疗阿尔茨海默病或缺血再灌注和损伤的情况。
    公开号:
    WO2004007475A1
  • 作为产物:
    描述:
    1-(3-烯丙基-2-羟基苯基)乙酮2,4,5-三甲氧基苯甲醛氢氧化钾 作用下, 以 乙醇 为溶剂, 反应 191.0h, 以100%的产率得到1-(2-hydroxy-3-allyl-phenyl)-3-(2,4,5-trimethoxy-phenyl)-propenone
    参考文献:
    名称:
    [EN] FLAVONOID COMPOUNDS AS THERAPEUTIC ANTIOXIDANTS
    [FR] COMPOSES FLAVONOIDES EN TANT QU'ANTIOXYDANTS THERAPEUTIQUES
    摘要:
    描述了具有抗氧化活性的新型黄酮类化合物。公式(1)。已经证明这些化合物在生物系统中展现出抗氧化特性,其在防晒霜或护肤品中的用途,或用于治疗涉及氧化损伤的情况,特别是治疗或预防治疗阿尔茨海默病或缺血再灌注和损伤的情况。
    公开号:
    WO2004007475A1
点击查看最新优质反应信息

文献信息

  • [EN] FLAVONOID COMPOUNDS AS THERAPEUTIC ANTIOXIDANTS<br/>[FR] COMPOSES FLAVONOIDES EN TANT QU'ANTIOXYDANTS THERAPEUTIQUES
    申请人:ROWETT RES INST
    公开号:WO2004007475A1
    公开(公告)日:2004-01-22
    Novel flavonoid compounds having anti-oxidant activity are described. Formula (1). The compounds have been shown to exhibit anti-oxidative properties in biological systems and their utility in a sunscreen or skincare composition or to treat conditions involving oxidative damage, especially curative or prophylactic treatment of Alzheimer's disease or ischaemia-reperfusion and injury, is described.
    描述了具有抗氧化活性的新型黄酮类化合物。公式(1)。已经证明这些化合物在生物系统中展现出抗氧化特性,其在防晒霜或护肤品中的用途,或用于治疗涉及氧化损伤的情况,特别是治疗或预防治疗阿尔茨海默病或缺血再灌注和损伤的情况。
  • US7601754B2
    申请人:——
    公开号:US7601754B2
    公开(公告)日:2009-10-13
  • Potential therapeutic antioxidants that combine the radical scavenging ability of myricetin and the lipophilic chain of vitamin E to effectively inhibit microsomal lipid peroxidation
    作者:Christopher J. Bennett、Stuart T. Caldwell、Donald B. McPhail、Philip C. Morrice、Garry G. Duthie、Richard C. Hartley
    DOI:10.1016/j.bmc.2004.02.031
    日期:2004.5
    The flavonol myricetin, reacts with oxygen-centred galvinoxyl radicals 28 times faster than d-alpha-tocopherol (vitamin E), the main lipid-soluble antioxidant in biological membranes. Moreover, each myricetin molecule reduces twice as many such radicals as vitamin E. However, myricetin fails to protect vitamin E-deficient microsomes from lipid peroxidation as assessed by the formation of thiobarbituric acid reactive substances (TBARS). Novel and potentially therapeutic antioxidants have been prepared that combine the radical-scavenging ability of a myricetin-like head group with a lipophilic chain similar to that of vitamin E. C-6-C-12 alkyl chains are attached to the A-ring of either a 3,3',4',5'-tetrahydroxyflavone or a 3,2',4',5'-tetrahydroxyflavone head group to give lipophilic flavonoids (Clog P = 4 to 10) that markedly inhibit iron-ADP catalysed oxidation of microsomal preparations. Orientation of the head group as well as total lipophilicity are important determinants of antioxidant efficacy. MM2 models indicate that our best straight chain 7-alkylflavonoids embed to the same depth in the membrane as vitamin E. The flavonoid head groups are prepared by aldol condensation followed by Algar-Flynn-Oyamada (AFO) oxidation or by Baker-Venkataraman re-arrangement. The alkyl tails are introduced by Suzuki or Negishi palladium-catalysed cross-coupling or by cross-metathesis catalysed by first generation Grubbs catalyst, which tolerate phenolic hydroxyl and ketone groups. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多